Publications

To showcase the world-class scientific research of the Claude Libert Lab, you can discover their scientific papers in more detail.

Selected publications

TNF-a inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

Dendoncker K*, Timmermans S*, Vandewalle J, Eggermont M, Lempiainen J, Paakinaho V, Van Hamme E, Dewaele S, Vandevyver S, Ballegeer M, Souffriau J, Van Wyngene L, Van Looveren K, Vanderhaeghen T, Beyaert R, De Bosscher K, Palvimo J, Van Montagu M@, Libert C@

(* CoFirst, @ Corresponding)

Proc Natl Acad Sci U S A

10.1073/pnas.1821565116

Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation

Vandevyver S, Dejager L, Van Bogaert T, Kleyman A, Liu Y, Tuckermann J, Libert C@

Complete overview of protein-inactivating sequence variations in 36 sequenced mouse inbred strains

Timmermans S, Van Montagu M@°, Libert C@°

(° CoLast, @ Corresponding)

Proc Natl Acad Sci U S A

9158-9163

114

2017

Glucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1

Puimège L, Van Hauwermeiren F, Steeland S, Van Ryckeghem S, Vandewalle J, Lodens S, Dejager L, Vandevyver S, Staelens J, Timmermans S, Vandenbroucke R°, Libert C@°

(° CoLast, @ Corresponding)

EMBO Mol Med

1004-17

2015

Hepatic PPARa function and lipid metabolic pathways are dysregulated in polymicrobial sepsis.

Van Wyngene L, Vanderhaeghen T, Timmermans S, Vandewalle J, Van Looveren K, Souffriau J, Wallaeys C, Eggermont M, Ernst S, Van Hamme E, Gonçalves A, Eelen G, Remmerie A, Scott C, Rombouts C, Vanhaecke L, De B, Decruyenaere J, Carmeliet P, Libert C@

10.15252/emmm.201911319

All our publications

Turning a pathogen protein into a therapeutic tool for sepsis.

Vanderhaeghen T, Wallaeys C, Libert C@

10.15252/emmm.202013589

Zinc inhibits lethal inflammatory shock by preventing microbe-induced interferon signature in intestinal epithelium.

Souffriau J*, Timmermans S*, Vanderhaeghen T, Wallaeys C, Van Looveren K, Aelbrecht L, Dewaele S, Vandewalle J, Goossens E, Verbanck S, Boyen F, Eggermont M, De Commer L, De Rycke R, De Bruyne M, Tito-Tadeo R, Ballegeer M, Vandevyver S, Velho T, Moita L, Hochepied T, De Bosscher K, Raes J, Van I, Beyaert R, Libert C@

(* CoFirst, @ Corresponding)

10.15252/emmm.201911917

Hepatic PPARa function and lipid metabolic pathways are dysregulated in polymicrobial sepsis.

10.15252/emmm.201911319

Taking the STING Out of Sepsis?

Vandewalle J, Vanderhaeghen T, Beyaert R, Libert C@

10.1016/j.chom.2020.03.016

Phytohormones: Multifunctional nutraceuticals against metabolic syndrome and comorbid diseases.

Kim S, Goossens A, Libert C, Van I, Staal J@, Beyaert R@

10.1016/j.bcp.2020.113866

Glucocorticoids limit lipopolysaccharide-induced lethal inflammation by a double control system.

Van Looveren K, Timmermans S, Vanderhaeghen T, Wallaeys C, Ballegeer M, Souffriau J, Eggermont M, Vandewalle J, Van Wyngene L, De Bosscher K, Libert C@

10.15252/embr.201949762

An extracellular microRNA can rescue lives in sepsis.

Van Looveren K, Van Wyngene L, Libert C@

10.15252/embr.201949193

Hypoxia-inducible factors in metabolic reprogramming during sepsis.

Vanderhaeghen T*, Vandewalle J*, Libert C@

(* CoFirst, @ Corresponding)

Glucocorticoids in Sepsis: To Be or Not to Be

Vandewalle J, Libert C@

(@ Corresponding)

FRONT IMMUNOL

1318

2020

Potential of glucocorticoids to treat intestinal inflammation during sepsis.

Van Looveren K*, Wallaeys C*, Libert C@

(* CoFirst, @ Corresponding)

10.1016/j.coph.2019.12.005